GSK, AstraZeneca rivalry takes center stage at cancer conference

Sep 27, 2019 , Reuters
GlaxoSmithKline and AstraZeneca will each present trial data on a promising new class of drugs against ovarian cancer on Saturday as Britain's top drugmakers compete to burnish their oncology credentials.

Read the full story...

Trending healthcare news keywords at this moment

coronavirus cases covid-